NO307548B1 - Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse - Google Patents

Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse

Info

Publication number
NO307548B1
NO307548B1 NO944405A NO944405A NO307548B1 NO 307548 B1 NO307548 B1 NO 307548B1 NO 944405 A NO944405 A NO 944405A NO 944405 A NO944405 A NO 944405A NO 307548 B1 NO307548 B1 NO 307548B1
Authority
NO
Norway
Prior art keywords
tablet
improved bioavailability
active compound
diphosphonic acid
dichloromethylene diphosphonic
Prior art date
Application number
NO944405A
Other languages
English (en)
Norwegian (no)
Other versions
NO944405D0 (no
NO944405L (no
Inventor
Walter Preis
Bernd Muesel
Guenter Neugebauer
Rolf-Dieter Gabel
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25927331&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO307548(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE9307393U external-priority patent/DE9307393U1/de
Priority claimed from DE19934322057 external-priority patent/DE4322057A1/de
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of NO944405D0 publication Critical patent/NO944405D0/no
Publication of NO944405L publication Critical patent/NO944405L/no
Publication of NO307548B1 publication Critical patent/NO307548B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO944405A 1993-05-15 1994-11-17 Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse NO307548B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE9307393U DE9307393U1 (de) 1993-05-15 1993-05-15 Tablette mit verbesserter Bioverfügbarkeit, enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
DE19934322057 DE4322057A1 (de) 1993-07-02 1993-07-02 Tablette mit verbesserter Bioverfügbarkeit enthaltend Dichlormethylendiphosphonsäure als Wirkstoff
PCT/EP1993/001967 WO1994026310A1 (de) 1993-05-15 1993-07-24 Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff

Publications (3)

Publication Number Publication Date
NO944405D0 NO944405D0 (no) 1994-11-17
NO944405L NO944405L (no) 1994-11-24
NO307548B1 true NO307548B1 (no) 2000-04-25

Family

ID=25927331

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944405A NO307548B1 (no) 1993-05-15 1994-11-17 Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse

Country Status (25)

Country Link
US (1) US5650168A (cs)
EP (2) EP0697890A1 (cs)
JP (1) JP3699110B2 (cs)
KR (1) KR100263284B1 (cs)
CN (1) CN1041797C (cs)
AT (2) ATE128363T1 (cs)
AU (1) AU687744B2 (cs)
BR (1) BR9307859A (cs)
CA (1) CA2162470C (cs)
CZ (1) CZ287984B6 (cs)
DE (1) DE59300688D1 (cs)
DK (1) DK0625355T5 (cs)
ES (1) ES2065313T5 (cs)
FI (1) FI111519B (cs)
GR (2) GR940300095T1 (cs)
HU (1) HU220872B1 (cs)
IL (1) IL106743A (cs)
NO (1) NO307548B1 (cs)
NZ (1) NZ254765A (cs)
PL (1) PL173026B1 (cs)
RU (1) RU2134103C1 (cs)
SK (1) SK281193B6 (cs)
TW (1) TW350772B (cs)
UA (1) UA39884C2 (cs)
WO (1) WO1994026310A1 (cs)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI94926C (fi) 1993-11-12 1995-11-27 Leiras Oy Menetelmä klodronaattivalmisteen valmistamiseksi
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
FI109088B (fi) * 1997-09-19 2002-05-31 Leiras Oy Tabletti ja menetelmä sen valmistamiseksi
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
SE9901272D0 (sv) * 1999-04-09 1999-04-09 Astra Ab New improved formulation
CZ20002567A3 (cs) * 2000-07-11 2001-12-12 Léčiva, A.S. Tableta vyrobitelná přímým tabletováním, obsahující aktivní látku kyselinu 4-amino-1-hydroxybutyliden-1,1-bisfosfonovou, a způsob její výroby
RU2192848C1 (ru) * 2001-10-30 2002-11-20 Закрытое акционерное общество "ВЕРОФАРМ" Противорвотное средство
EA013106B1 (ru) * 2003-09-19 2010-02-26 Сан Фарма Адвансед Ресьорч Компани Лтд. Оральная система доставки лекарственного препарата (варианты)
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US7151400B2 (en) * 2004-07-13 2006-12-19 Taiwan Semiconductor Manufacturing Company, Ltd. Boost-biased level shifter
CN100370972C (zh) * 2006-01-10 2008-02-27 北京申科联华科技有限公司 一种具有益气养阴、活血复脉功效的片剂及制备方法
WO2009017222A1 (ja) * 2007-08-02 2009-02-05 Teijin Pharma Limited 骨代謝異常に起因する疾患の予防剤又は治療剤
MX2010008861A (es) * 2008-02-15 2011-02-22 Sun Pharma Advanced Res Co Ltd Tableta oral de liberacion controlada con efecto de liberacion masiva reducido.
CN118370733B (zh) * 2024-06-21 2024-10-01 山东新时代药业有限公司 一种钙代谢调节药物氯膦酸二钠片及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH9776A (en) * 1967-12-11 1976-03-17 M Francis Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue and method of use
DE2813121A1 (de) * 1977-03-29 1978-10-12 Procter & Gamble Verwendung von dichlormethan-diphosphonatverbindungen bei der bekaempfung von collagen-erkrankungen und zur wundheilung
US4634691A (en) * 1980-10-07 1987-01-06 The Procter & Gamble Company Method for inhibiting tumor metastasis
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
SU1437023A1 (ru) * 1986-01-02 1988-11-15 Всесоюзный научно-исследовательский институт химии и технологии лекарственных средств Антацидное средство "Кальмагин
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
ES2040733T3 (es) * 1986-12-20 1993-11-01 Boehringer Mannheim Gmbh Medicamentos que contienen clodronato y procedimiento para su preparacion.
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten
FR2629716B1 (fr) * 1988-04-07 1991-07-19 Sanofi Sa Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique
FI83421C (fi) † 1989-06-21 1991-07-10 Huhtamaeki Oy Foerfarande foer framstaellning av farmakologiskt anvaendbara metylenbisfosfonsyraderivat.
HU215124B (hu) * 1991-02-26 1998-09-28 Norwich Eaton Pharmaceuticals, Inc. Eljárás csontritkulás (osteoporosis) kezelésére szolgáló ösztrogént és difoszfonátot tartalmazó, szinergetikus hatású gyógyszerkészítmények előállítására
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
JPH08505142A (ja) * 1992-12-23 1996-06-04 メルク エンド カンパニー インコーポレーテッド 骨損失を治療及び予防するためのビスホスホネート／エストロゲン療法

Also Published As

Publication number Publication date
US5650168A (en) 1997-07-22
CN1095267A (zh) 1994-11-23
JPH08509697A (ja) 1996-10-15
EP0625355B2 (de) 2003-06-25
DE59300688D1 (de) 1995-11-02
HU9403160D0 (en) 1995-02-28
IL106743A0 (en) 1993-12-08
JP3699110B2 (ja) 2005-09-28
BR9307859A (pt) 1996-01-09
AU687744B2 (en) 1998-03-05
GR940300095T1 (en) 1995-01-31
KR960702322A (ko) 1996-04-27
HU220872B1 (en) 2002-06-29
ES2065313T5 (es) 2004-01-01
ES2065313T3 (es) 1995-12-01
SK4895A3 (en) 1997-01-08
AT128U1 (de) 1995-03-27
RU2134103C1 (ru) 1999-08-10
IL106743A (en) 1999-11-30
PL307133A1 (en) 1995-05-02
CZ287984B6 (cs) 2001-03-14
FI945313A0 (fi) 1994-11-11
EP0625355B1 (de) 1995-09-27
CN1041797C (zh) 1999-01-27
ES2065313T1 (es) 1995-02-16
DK0625355T5 (da) 2003-12-01
EP0697890A1 (de) 1996-02-28
FI111519B (fi) 2003-08-15
HUT70214A (en) 1995-09-28
DK0625355T3 (da) 1995-12-27
EP0625355A1 (de) 1994-11-23
TW350772B (en) 1999-01-21
UA39884C2 (uk) 2001-07-16
FI945313L (fi) 1994-12-13
WO1994026310A1 (de) 1994-11-24
CA2162470C (en) 1998-06-16
NZ254765A (en) 1997-02-24
GR3017547T3 (en) 1995-12-31
KR100263284B1 (ko) 2000-08-01
NO944405D0 (no) 1994-11-17
CZ10095A3 (en) 1995-10-18
SK281193B6 (sk) 2001-01-18
NO944405L (no) 1994-11-24
PL173026B1 (pl) 1998-01-30
DK0625355T4 (da) 2003-10-06
CA2162470A1 (en) 1994-11-24
ATE128363T1 (de) 1995-10-15
AU4702093A (en) 1994-12-12

Similar Documents

Publication Publication Date Title
NO307548B1 (no) Tablett med forbedret biologisk tilgjengelighet inneholdende diklormetylendifosfonsyre som aktiv forbindelse
DK1027037T3 (da) Farmaceutisk præparat som indeholder clodronat som aktiv ingrediens og forkislet mikrokrystallinsk cellulose som excipiens
DK0497158T3 (da) Farmaceutisk tyggegummi med acetylsalicylsyre
FI944035A0 (fi) Tramadolisuolaa sisältävä lääkeaine, jolla on viivästynyt vaikuttavan aineen vapautuminen
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
NZ279062A (en) Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer
FI885460L (fi) Menetelmä suun kautta annettavaksi tarkoitetun, aktiiviyhdistettä kontrolloidusti vapauttavan farmaseuttisen formulaation valmistamiseksi
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
ES2010466A6 (es) Formas de administracion solidas, de rapida desintegracion.
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
NO178336C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv benzimidazolforbindelse og mellomprodukter
HUT50334A (en) Process for producing arylpiperazinyl-alkilenephenyl-p-heterocycluc compounds, pharmaceutically acceptable acid addition salts thereof and pharmaceutical compositions comprising the compounds as active ingredient
AP9901474A0 (en) Pharmaceutical composition for treating viral diseases.
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft
DK0667151T3 (da) Oralt lægemiddelpræparat indeholdende diclofenacnatrium og en organisk syre
ZA824649B (en) New optically active dipeptides, process for their preparation and pharmaceutical products containing these compounds
SE8105500L (sv) Psykotropa lekemedel
SE8401968L (sv) Forfarande for framstellning av vel absorberbara orala lekemedelsdoseringsformer av medicinska 1,4-dihydropyridinderivat
IT1271354B (it) Preparazione di una forma farmaceutica atta a combattere l'iperinsulinismo contenente n-acetil cisteine e loro analoghi
RU93058142A (ru) Производные хинолина, способ их получения, фармацевтическая композиция и способ лечения
UA31437A (uk) Спосіб одержання лікарського засобу "йохімбін гідрохлорид" у формі таблеток
UA27223C2 (uk) Тверда лікарська форма, що містить іфосфамід

Legal Events

Date Code Title Description
MK1K Patent expired